Examines chemical variability in Epilobium herbal tea, suggesting better quality assessment is needed.
BACKGROUND: herb are widely consumed in Europe for prostate-related and anti-inflammatory effects. However, they are often sold under generic names without clear species differentiation or quality specifications, raising concerns about chemical consistency and therapeutic equivalence. OBJECTIVE: products and refine the framework for quality marker selection by integrating pharmacological relevance with structural assessment. MATERIALS AND METHODS: Pan-Assay Interference Compounds (PAINS) structural filters. RESULTS: < 0.05). Flavonol glycosides (e.g., hyperoside, isoquercitrin) also varied substantially. Although species identity influenced phenolic profiles, overlapping concentration ranges indicated a lack of chemical equivalence among products. Geographic origin contributed additional but secondary variability. DISCUSSION: Oenothein B, hyperoside, and isoquercitrin were identified as priority quality markers based on abundance and analytical suitability. Structural reassessment demonstrated that pharmacological ranking alone may be misleading for polyphenol-rich matrices due to redox-related interference. CONCLUSION: teas differ chemically and are not interchangeable. A structure-informed approach is essential for reliable quality assessment and for aligning commercial products with pharmacopeial standards.
No takes yet. Share an insight, caveat, or question.
Mykhailenko et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: